These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 12202892)

  • 21. [Oral cancer: morbus Hungaricus in the 21st century].
    Suba Z; Mihályi S; Takács D; Gyulai-Gaál S
    Fogorv Sz; 2009 Apr; 102(2):63-8. PubMed ID: 19514245
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prostate cancer incidence in guadeloupe, a French Caribbean archipelago.
    Mallick S; Blanchet P; Multigner L
    Eur Urol; 2005 Jun; 47(6):769-72. PubMed ID: 15925071
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cancer mortality and incidence in Hungary in relation to international data].
    Ottó S; Kásler M
    Magy Onkol; 2002; 46(2):111-7. PubMed ID: 12202890
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An ecologic study of prostate-specific antigen screening and prostate cancer mortality in nine geographic areas of the United States.
    Shaw PA; Etzioni R; Zeliadt SB; Mariotto A; Karnofski K; Penson DF; Weiss NS; Feuer EJ
    Am J Epidemiol; 2004 Dec; 160(11):1059-69. PubMed ID: 15561985
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The increasing incidence of prostate cancer in Hungary.
    Sapi Z; Bodo M; Vadasz G; Henson DE; Haas GP
    In Vivo; 1994; 8(3):433-5. PubMed ID: 7803729
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mass screening for prostate cancer in Korea: a population based study.
    Song C; Ahn H; Lee MS; Park J; Kwon TG; Kim HJ; Choi HY;
    J Urol; 2008 Nov; 180(5):1949-52; discussion 1952-3. PubMed ID: 18801541
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pesticide sales and adult male cancer mortality in Brazil.
    Chrisman Jde R; Koifman S; de Novaes Sarcinelli P; Moreira JC; Koifman RJ; Meyer A
    Int J Hyg Environ Health; 2009 May; 212(3):310-21. PubMed ID: 18838335
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Place of residence effect on likelihood of surviving prostate cancer.
    Gregorio DI; Huang L; DeChello LM; Samociuk H; Kulldorff M
    Ann Epidemiol; 2007 Jul; 17(7):520-4. PubMed ID: 17448679
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk of cardiovascular mortality in prostate cancer patients in the Rotterdam randomized screening trial.
    Otto SJ; Schröder FH; de Koning HJ
    J Clin Oncol; 2006 Sep; 24(25):4184-9. PubMed ID: 16943535
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Geographically based investigation of prostate cancer mortality in four U.S. Northern Plain states.
    Rusiecki JA; Kulldorff M; Nuckols JR; Song C; Ward MH
    Am J Prev Med; 2006 Feb; 30(2 Suppl):S101-8. PubMed ID: 16458784
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prostate cancer and prostate-specific antigen (PSA) screening in Austria.
    Vutuc C; Schernhammer ES; Haidinger G; Waldhör T
    Wien Klin Wochenschr; 2005 Jul; 117(13-14):457-61. PubMed ID: 16091872
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Excess mortality of hepatocellular carcinoma and morbidity of liver cirrhosis and hepatitis in HCV-endemic areas in an HBV-endemic country: geographic variations among 502 villages in southern Taiwan.
    Tsai MC; Kee KM; Chen YD; Lin LC; Tsai LS; Chen HH; Lu SN
    J Gastroenterol Hepatol; 2007 Jan; 22(1):92-8. PubMed ID: 17201888
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High prostate cancer mortality in Norway evaluated by automated classification of medical entities.
    Hernes E; Johansson LA; Fosså SD; Pedersen AG; Glattre E
    Eur J Cancer Prev; 2008 Aug; 17(4):331-5. PubMed ID: 18562957
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prostate disease prevalence with epidemiological and hormonal analysis in randomly selected male population in Croatia.
    Galić J; Simunović D
    Coll Antropol; 2008 Dec; 32(4):1195-202. PubMed ID: 19149228
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Epidemiology of germinal cell testicular tumor in Hungary].
    Klujber V; Baki M; Bodrogi I
    Orv Hetil; 1990 May; 131(18):975-8. PubMed ID: 2189094
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of prostate-specific antigen and hormone levels among men in Singapore and the United States.
    Cheng I; Yu MC; Koh WP; Pike MC; Kolonel LN; Henderson BE; Stram DO
    Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1692-6. PubMed ID: 16030103
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Calculated fast-growing benign prostatic hyperplasia--a risk factor for developing clinical prostate cancer.
    Hammarsten J; Högstedt B
    Scand J Urol Nephrol; 2002; 36(5):330-8. PubMed ID: 12487736
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changing demography of prostate cancer in Asia.
    Sim HG; Cheng CW
    Eur J Cancer; 2005 Apr; 41(6):834-45. PubMed ID: 15808953
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prospective assessment of patient-reported long-term urinary morbidity and associated quality of life changes after 125I prostate brachytherapy.
    Stone NN; Stock RG
    Brachytherapy; 2003; 2(1):32-9. PubMed ID: 15062161
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interpreting trends in prostate cancer incidence and mortality in the five Nordic countries.
    Kvåle R; Auvinen A; Adami HO; Klint A; Hernes E; Møller B; Pukkala E; Storm HH; Tryggvadottir L; Tretli S; Wahlqvist R; Weiderpass E; Bray F
    J Natl Cancer Inst; 2007 Dec; 99(24):1881-7. PubMed ID: 18073376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.